Taurine (2-Aminoethanesulfonic Acid): A Comprehensive Monograph on its Chemistry, Physiology, Pharmacology, and Therapeutic Potential

I. Executive Summary

Taurine, chemically known as 2-aminoethanesulfonic acid, is a unique, sulfur-containing organic compound ubiquitously distributed throughout mammalian tissues. Structurally, it is an amino sulfonic acid, a distinction that sets it apart from the canonical alpha-amino acids that constitute proteins.[1] This structural feature renders it non-proteinogenic, yet it is one of the most abundant free amino acids in the body. It is classified as a "conditionally essential" nutrient, reflecting its critical role in neonatal development and certain pathological states, which can outstrip the capacity of endogenous synthesis in healthy adults.[3]

Physiologically and pharmacologically, taurine's significance is underscored by its exceptionally high concentrations in excitable tissues such as the brain, retina, heart, and skeletal muscle.[1] Its biological importance stems from a diverse array of fundamental cellular functions. These include its roles as a primary organic osmolyte in cell volume regulation, a substrate for the conjugation of bile acids essential for lipid digestion, a modulator of intracellular calcium homeostasis critical for cardiac and neuronal function, and a potent cytoprotective agent with both antioxidant and anti-inflammatory properties.[6] These multifaceted physiological roles provide the foundation for its broad and complex pharmacological activities.

From a therapeutic standpoint, taurine has established applications and a growing portfolio of investigated uses. It is a standard ingredient in parenteral nutrition solutions, particularly for pediatric patients, to support normal development and prevent deficiency-related pathologies.[8] Notably, it has been officially approved in Japan for the treatment of congestive heart failure, a testament to its recognized cardiovascular benefits.[9] Beyond these established uses, taurine is the subject of extensive research for its potential in a range of conditions. Promising, though not yet definitively proven, therapeutic areas include metabolic diseases such as type 2 diabetes, where it may improve insulin sensitivity; hepatitis, where it may support liver function; various neurodegenerative conditions, due to its neuroprotective effects; and the enhancement of athletic performance.[11]

The safety profile of taurine is well-established and favorable at typical supplemental doses, with an observed safe upper limit of 3 grams per day, although doses up to 6 g/day have been used in clinical trials without significant adverse events.[12] Nevertheless, caution is warranted regarding potential drug-drug interactions, particularly with antihypertensive agents and lithium, where taurine can potentiate their effects or alter their clearance.[11] Recent preclinical findings also suggest a context-dependent role in the microenvironment of certain cancers, such as leukemia, which calls for a more nuanced approach to its supplementation in specific patient populations.[15] Its regulatory status is complex and varies globally; it is classified as a food ingredient, a dietary supplement, or a therapeutic good depending on the jurisdiction, formulation, and intended use.[16]

In conclusion, taurine is a molecule of profound biological importance whose full therapeutic potential is still being actively explored. While its fundamental physiological roles are well-characterized, its capacity to act as a pharmacological agent to modulate disease pathways requires further validation through large-scale, rigorously designed clinical trials. The existing body of evidence positions taurine as a promising candidate for future therapeutic development across a spectrum of clinical conditions.[18]

II. Chemical Identity and Physicochemical Properties

2.1. Nomenclature and Identifiers

The precise identification of taurine is established through a comprehensive set of internationally recognized names and registry numbers, which are essential for unambiguous reference in scientific, regulatory, and commercial contexts.

• Preferred IUPAC Name: 2-Aminoethanesulfonic acid.[20]
• Common Names and Synonyms: Taurine is the most widely used common name. Other synonyms include Tauric acid, β-Aminoethylsulfonic acid, and Aminoethanesulfonic acid.[3]
• Registry Numbers:
• CAS Number: The primary Chemical Abstracts Service (CAS) registry number for taurine is 107-35-7.[3] Several deprecated CAS numbers also exist, including 1365481-05-5 and 91105-79-2.[3]
• DrugBank ID: DB01956.[3]
• PubChem CID: 1123.[20]
• Other Key Identifiers: Its identity is further specified by numerous database entries, including the European Community (EC) Number 203-483-8, the FDA Unique Ingredient Identifier (UNII) 1EQV5MLY3D, the Chemical Entities of Biological Interest (ChEBI) ID CHEBI:15891, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) IDs C00245 and D00047.[3]

2.2. Molecular Structure and Properties

• Chemical Formula: The empirical formula for taurine is C2​H7​NO3​S.[2]
• Molecular Weight: The molecular weight is consistently reported as approximately 125.15 g/mol (or more precisely, 125.147 g/mol).[6]
• Structural Features: Taurine is an amino sulfonic acid, structurally distinct from the 20 proteinogenic alpha-amino acids which contain a carboxylic acid group. At physiological pH, taurine exists as a zwitterion with the formula H3​N+CH2​CH2​SO3−​, a structure confirmed by X-ray crystallography.[20] This zwitterionic state is a consequence of the chemical properties of its two functional groups. The sulfonic acid group has a very low acid dissociation constant ( pKa​) of approximately 1.5, ensuring it is fully deprotonated and negatively charged at physiological pH.[6] The amino group, being basic, is protonated and positively charged. This permanent zwitterionic character is the fundamental chemical property that dictates much of its physiological profile. It is the root cause of its high water solubility, its function as an osmolyte, and its inability to form the peptide bonds necessary for protein synthesis, thereby classifying it as a non-proteinogenic amino acid.[20]
• Computed Properties: Computational analysis provides further insight into its molecular characteristics. Its Topological Polar Surface Area (TPSA) is 88.8 Ų, indicating a high degree of polarity. It has two hydrogen bond donors (from the ammonium group) and four hydrogen bond acceptors (from the sulfonate group and the nitrogen atom), and two rotatable bonds, which gives it some conformational flexibility.[3]

2.3. Physical and Chemical Characteristics

• Appearance: Taurine is a solid that appears as large white crystals, a white to almost-white crystalline powder, or as colorless monoclinic prisms when crystallized from water.[3]
• Solubility: Consistent with its polar, zwitterionic nature, taurine is highly soluble in water, with reported values of 50 to 100 mg/mL or 79 g/L at 20 °C.[23] It is sparingly soluble in organic solvents like ethanol and ether.[23]
• Melting Point: Taurine does not have a true melting point; instead, it decomposes at high temperatures, typically cited as being greater than 300 °C (572 °F).[6]
• Stability: The compound is stable under normal storage conditions but is noted to be incompatible with strong oxidizing agents.[6] For preservation, it is recommended to be stored at either room temperature or refrigerated (2–8 °C), and protected from light and moisture to prevent degradation.[6]

A consolidated table of these properties provides a comprehensive reference for the molecule's identity.

Property	Value	Source(s)
IUPAC Name	2-Aminoethanesulfonic acid	20
CAS Number	107-35-7	3
DrugBank ID	DB01956	3
Molecular Formula	C2​H7​NO3​S	2
Molecular Weight	125.15 g/mol	3
Appearance	White crystalline powder or colorless crystals	3
Solubility in Water	79 g/L (at 20 °C)	23
Melting Point	>300 °C (decomposes)	6
pKa	1.5 (sulfonic acid group)	6
Topological Polar Surface Area	88.8 Ų	3

The unique chemical architecture of taurine, specifically the presence of a sulfonic acid group instead of a carboxylic acid group, is not merely a structural footnote but the central determinant of its biological role. This single substitution dictates a cascade of physicochemical properties that, in turn, define its physiological functions. The sulfonic acid's low pKa ensures that at any pH found within the human body, the molecule exists as a zwitterion, with a permanent negative charge on the sulfonate end and a positive charge on the ammonium end. This charge separation is responsible for its high polarity and, consequently, its excellent solubility in the aqueous environment of the cell's cytoplasm. This high solubility allows it to accumulate to high intracellular concentrations, which is the prerequisite for its function as a major organic osmolyte, a molecule that cells use to regulate their volume and protect against osmotic stress. Simultaneously, the absence of a carboxyl group prevents it from participating in the formation of peptide bonds, the fundamental linkage of protein structures. This classifies it as a non-proteinogenic amino acid, meaning it remains as a free molecule within the cell, available to perform its diverse regulatory functions rather than being sequestered into structural proteins. Thus, a clear and direct line can be drawn from its core chemical structure to its most important physiological roles and metabolic classification, illustrating a powerful example of the structure-function relationship in biochemistry.

III. Biosynthesis, Distribution, and Physiological Significance

3.1. Endogenous Synthesis and Dietary Requirement

Taurine's classification as a "conditionally essential" or "semi-essential" amino acid stems from the variable capacity of the human body to synthesize it relative to its physiological demand.[3] While healthy adults can typically produce sufficient quantities, certain conditions of life stage or health can render endogenous synthesis inadequate, making dietary intake essential.

• Biosynthesis Pathways: The primary route for taurine synthesis in mammals is the "cysteine sulfinic acid pathway," which predominantly occurs in the liver and, to some extent, the central nervous system.[20] This multi-step enzymatic process begins with the amino acid cysteine, which is derived from the essential amino acid methionine via the transsulfuration pathway.[20] The key steps are:

1. Oxidation: Cysteine is first oxidized to cysteine sulfinic acid, a reaction catalyzed by the enzyme cysteine dioxygenase (CDO).[4]
2. Decarboxylation: Cysteine sulfinic acid is then decarboxylated to form hypotaurine. This is considered the rate-limiting step in taurine biosynthesis and is catalyzed by sulfinoalanine decarboxylase, also known as cysteinesulfinate decarboxylase (CSD).[20]
3. Final Oxidation: Hypotaurine is subsequently oxidized to yield the final product, taurine.[4]

The entire pathway is dependent on several cofactors, most notably pyridoxal-5'-phosphate, the active form of vitamin B6, which is required for the activity of CSD.1

• Conditionally Essential Status: The human liver's capacity for taurine synthesis is relatively low compared to that of other mammals, making dietary sources a significant contributor to the body's total pool.[19] This limited synthetic capacity becomes critically important in specific populations. Neonates, and particularly premature infants, have immature enzyme systems and thus a very limited ability to synthesize taurine, making it an essential nutrient that must be supplied through breast milk or fortified formula for normal development of the brain and retina.[1] Furthermore, various pathological states, such as chronic liver or kidney disease, or severe metabolic stress, can impair the body's ability to produce or retain taurine, thereby increasing the dietary requirement.[29] This concept of conditional essentiality is not merely a nutritional detail but a crucial indicator of metabolic vulnerability. It establishes a direct link between dietary patterns, such as strict veganism, or specific health conditions, and the risk of developing severe pathologies like cardiomyopathy and retinal degeneration. This understanding transforms the view of taurine from a simple nutrient to a potential medical necessity for identifiable at-risk populations.

3.2. Dietary Sources and Bioavailability

• Food Sources: Taurine is found almost exclusively in foods of animal origin.[20] The highest concentrations are found in seafood and meat.[3] Exceptionally rich sources include shellfish, such as scallops (up to 827 mg/100g) and mussels (up to 655 mg/100g); certain fish, like tuna (up to 964 mg/100g); and the dark meat of poultry, such as turkey (up to 306 mg/100g).[32] In contrast, taurine content is low or negligible in most plant-based foods, which is a significant consideration for individuals following vegetarian or vegan diets.[20] A notable exception in the plant kingdom is certain types of seaweed, particularly nori, which can contain substantial amounts.[31]
• Dietary Intake: The average daily intake of taurine in a typical Western omnivorous diet is estimated to be between 40 and 400 mg.[11] This is considerably lower than the multi-gram doses often used in clinical studies for therapeutic purposes.[35]
• Absorption: Taurine from the diet is absorbed in the small intestine. This process is mediated by at least two distinct transport systems: the high-affinity, low-capacity, sodium- and chloride-dependent taurine transporter (TauT, encoded by the gene SLC6A6), and the low-affinity, high-capacity, proton-coupled amino acid transporter 1 (PAT1, encoded by SLC36A1).[26]

3.3. Tissue Distribution and Homeostasis

• Distribution: Following absorption and endogenous synthesis, taurine is distributed throughout the body, where it becomes one of the most abundant free amino acids intracellularly.[3] It is particularly concentrated in tissues with high electrical activity or high exposure to oxidative stress. These include the retina, brain, heart, skeletal muscle, and leukocytes.[1] The total amount of taurine in a 70 kg human is estimated to be around 70 g.[5] The largest single reservoir of taurine in the body is skeletal muscle, which accounts for over 70% of the total pool.[26]
• Homeostasis: Cells maintain very high intracellular concentrations of taurine (ranging from 5 to 50 mM) against a much lower plasma concentration (typically 50–200 µM).[5] This steep concentration gradient is actively maintained by the TauT transporter, which pumps taurine into the cells.[26] Overall body homeostasis is primarily regulated by the kidneys, which can either conserve taurine through highly efficient tubular reabsorption when dietary intake is low or excrete excess taurine in the urine when intake is high.[5]

3.4. Fundamental Physiological Roles

The widespread distribution and high concentration of taurine are indicative of its involvement in a multitude of fundamental biological processes that are critical for cellular and organismal health.

• Osmoregulation: As a major organic osmolyte, taurine is vital for the regulation of cell volume. Cells in tissues like the brain and heart accumulate or release taurine to counteract changes in extracellular osmotic pressure, thereby preventing cellular swelling (cytotoxic edema) or shrinkage and maintaining normal cell function.[6]
• Bile Acid Conjugation: In the liver, taurine is conjugated with bile acids (such as cholic acid) to form bile salts (e.g., taurocholic acid).[8] These conjugated bile salts are essential components of bile and act as detergents in the intestine, facilitating the emulsification, digestion, and absorption of dietary fats and fat-soluble vitamins.[19]
• Neuromodulation: Within the central nervous system, taurine functions as an inhibitory neuromodulator, acting on various receptor systems to dampen neuronal excitability. It stabilizes cell membranes and facilitates the transport of key ions like sodium, potassium, calcium, and magnesium, which are crucial for maintaining the electrochemical gradients necessary for nerve impulse transmission.[1]
• Calcium Homeostasis: Taurine plays a pivotal role in modulating intracellular free calcium ([Ca2+]i​) concentrations. This is particularly important in electrically excitable cells like cardiomyocytes and neurons. By regulating calcium flux across the cell membrane and into and out of intracellular stores like the sarcoplasmic reticulum, taurine helps ensure proper muscle contraction and relaxation and protects cells from the toxic effects of calcium overload.[19]
• Antioxidant and Anti-inflammatory Effects: Taurine possesses significant cytoprotective properties. It acts as a direct antioxidant by scavenging reactive oxygen species (ROS) and, more importantly, as an indirect antioxidant through its reaction with hypochlorous acid (HOCl). HOCl is a potent oxidant produced by neutrophils at sites of inflammation. Taurine rapidly neutralizes HOCl to form taurine chloramine (TauCl), a much less toxic and more stable compound that itself exhibits anti-inflammatory and antimicrobial activities.[6] This mechanism is a key component of its protective role in inflammatory conditions.

IV. Comprehensive Pharmacological Profile

The diverse physiological functions of taurine form the basis of its complex pharmacological profile. When administered at supraphysiological doses, taurine can modulate multiple biological systems, exhibiting effects that range from neuromodulation to cardiovascular regulation and metabolic control.

4.1. Pharmacodynamics (Mechanism of Action)

Taurine's mechanisms of action are multifaceted, involving direct interactions with cell surface receptors, regulation of intracellular signaling pathways, and profound effects on mitochondrial function.

• CNS Receptor Interactions: Taurine's role as a neuromodulator is mediated by its interaction with several key inhibitory and excitatory receptor systems in the central nervous system.
• GABAergic System: It is a direct agonist at both gamma-aminobutyric acid type A (GABA(A)) and type B (GABA(B)) receptors.[8] Its action at the ionotropic GABA(A) receptor contributes to neuronal hyperpolarization and underlies its inhibitory, anticonvulsant, and anxiolytic properties.[1] This explains the potential for pharmacodynamic synergy with other GABAergic drugs like benzodiazepines.[39]
• Glycinergic System: Taurine also acts as an agonist at inhibitory glycine receptors, particularly the alpha-1, alpha-2, and alpha-3 subunits.[8] This action contributes to its overall inhibitory tone in the spinal cord and brainstem.
• Glutamatergic System: It provides a neuroprotective effect by acting as an inhibitor of the NMDA receptor, specifically targeting the 2B subunit.[8] This action helps to counteract glutamate-induced excitotoxicity, a pathological process implicated in ischemic brain injury and neurodegenerative diseases.[22]
• Mitochondrial and Metabolic Regulation: Taurine is fundamentally important for mitochondrial health and energy metabolism. Its therapeutic efficacy in the mitochondrial disease MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) provides a powerful clinical validation of its core mitochondrial mechanism. MELAS is often caused by mutations in mitochondrial tRNA that impair the conjugation of taurine to form 5-taurinomethyluridine, a modification necessary for the efficient translation of certain mitochondrial-encoded proteins.[19] This specific molecular defect leads to a cascade of mitochondrial dysfunction. The fact that supraphysiological doses of taurine can overcome this defect and restore mitochondrial function is not merely a niche application; it is a clinical proof-of-concept for its fundamental role.[9] This lends significant weight to the hypothesis that taurine's benefits in other conditions associated with mitochondrial decline, such as heart failure and aging, may be driven by this same potent mechanism.
• Mitochondrial Protein Synthesis: Taurine is conjugated to the uridine nucleotide at the "wobble" position of the anticodon of certain mitochondrial tRNAs (e.g., tRNALeu(UUR)).[8] This modification is essential for the accurate and efficient translation of mitochondrial-encoded proteins, such as ND6, a critical subunit of Complex I of the electron transport chain. Taurine deficiency leads to impaired synthesis of these proteins, resulting in reduced Complex I activity, decreased ATP production, and increased generation of damaging superoxide radicals.[19]
• Energy Metabolism: By restoring Complex I function, taurine helps to normalize the cellular redox state, specifically the NADH/NAD+ ratio. In taurine-deficient states, an elevated NADH/NAD+ ratio leads to feedback inhibition of key dehydrogenases in both the citric acid cycle and glycolysis (e.g., pyruvate dehydrogenase), severely impairing the oxidation of both glucose and fatty acids.[19]
• Cardiovascular Mechanisms:
• Calcium Modulation: In cardiomyocytes, taurine helps maintain calcium homeostasis. It regulates the activity of the sarcoplasmic reticulum Ca2+-ATPase (SERCA) and the sarcolemmal Na+/Ca2+ exchanger, which enhances cardiac contractility and improves diastolic relaxation without inducing the detrimental effects of calcium overload.[19]
• Antagonism of Angiotensin II: Taurine has been shown to counteract many of the pathological actions of angiotensin II, a key hormone in the renin-angiotensin system. It attenuates angiotensin II-induced vasoconstriction, cellular hypertrophy, and downstream signaling, a mechanism that provides a rationale for its use in hypertension and heart failure.[29]
• Anti-inflammatory and Cytoprotective Mechanisms:
• Hypochlorous Acid Neutralization: At sites of inflammation, taurine serves as a primary scavenger of hypochlorous acid (HOCl), a highly reactive oxidant produced by the enzyme myeloperoxidase in neutrophils.[6] The reaction produces taurine chloramine (TauCl), a more stable and less toxic compound that retains antimicrobial properties and also actively suppresses the inflammatory cascade by inhibiting the production of pro-inflammatory cytokines.[6]
• ER Stress Attenuation: Taurine can mitigate endoplasmic reticulum (ER) stress, a cellular stress response implicated in a variety of diseases. By improving protein folding capacity within the ER, taurine helps prevent the activation of apoptotic pathways, contributing to its neuroprotective effects in conditions like stroke and Alzheimer's disease.[9]

4.2. Pharmacokinetics

The pharmacokinetic profile of taurine is characterized by rapid absorption, wide distribution with active tissue uptake, limited metabolism, and efficient renal regulation.

• Absorption: When administered orally, taurine is readily absorbed from the gastrointestinal tract. Studies in healthy volunteers have shown that the time to reach maximum plasma concentration (Tmax​) is approximately 1.5 hours following a 4 g oral dose.[8]
• Distribution: Taurine is distributed throughout the body via the circulatory system. It is actively transported into cells, particularly in the brain, heart, and muscle, against a significant concentration gradient, leading to high intracellular levels.[8] It is capable of crossing the blood-brain barrier, which is essential for its neurological functions.[37]
• Metabolism: Taurine is not extensively metabolized in humans. The main metabolic pathways involve conjugation rather than degradation.
• In the liver, it is conjugated with bile acids by the enzyme bile acid-CoA:amino acid N-acyltransferase to form bile salts like taurocholate.[8]
• A minor pathway involves its reaction with glutamate, catalyzed by gamma-glutamyltransferase 6, to form 5-glutamyl-taurine.[8]
• Elimination: The primary route of elimination for the body's taurine pool is believed to be through the gut, driven by the enterohepatic circulation of bile salts.[8] The kidneys also play a crucial role in maintaining homeostasis by regulating its excretion in the urine. The plasma elimination half-life ( t1/2​) is relatively short, reported to be approximately 1.0 hour in healthy individuals after an oral dose.[8] The clearance rate is dose-dependent, with studies reporting values ranging from 9.4 to 18.7 mL/min/kg for oral doses between 1 and 30 mg/kg.[8]

V. Clinical Evidence and Therapeutic Applications

The therapeutic potential of taurine has been explored across a wide range of clinical conditions, from established roles in nutritional support to promising applications in cardiovascular and metabolic diseases. The evidence base varies significantly by indication, with some uses supported by robust clinical trials while others remain speculative.

5.1. Established and Approved Indications

• Nutritional Support (Parenteral Nutrition): Taurine is a standard and essential component of parenteral nutrition (PN) formulations, especially for neonatal and pediatric populations.[8] Its inclusion is critical to prevent the consequences of deficiency, which can arise due to the immature synthetic pathways in infants. Taurine deficiency in this population is associated with impaired retinal development, abnormal electroretinograms, and poor growth.[46] Recommended dosages in pediatric PN aim to replicate the plasma levels found in breastfed infants, typically around 0.05 g/kg/day.[47] It is also considered a necessary additive for adults on long-term PN to prevent cholestasis and other complications.[48]
• Congestive Heart Failure (Japan): In Japan, taurine is an approved pharmaceutical agent for the treatment of congestive heart failure (CHF).[9] This approval is based on clinical trials demonstrating that oral supplementation can significantly improve cardiac function and patient outcomes. Studies have shown that taurine improves left ventricular ejection fraction (LVEF), enhances exercise capacity, and reduces symptoms such as dyspnea and palpitations in patients with New York Heart Association (NYHA) functional class II to IV heart failure.[50] The typical therapeutic dosage ranges from 2 to 6 g per day, administered in divided doses.[50] A 2024 meta-analysis further substantiated these findings, confirming that taurine supplementation leads to statistically significant improvements in heart rate, blood pressure, and NYHA functional class.[53]

5.2. Investigated Cardiovascular Applications

• Hypertension: A growing body of evidence supports taurine's role in blood pressure regulation. A notable randomized, double-blind, placebo-controlled study involving 120 prehypertensive individuals demonstrated that supplementation with 1.6 g of taurine daily for 12 weeks resulted in a significant reduction in both clinic and 24-hour ambulatory blood pressure.[42] The effect was more pronounced in subjects with high-normal blood pressure, with a mean clinic systolic blood pressure reduction of 7.2 mmHg compared to 2.6 mmHg in the placebo group. The proposed mechanism involves improved endothelium-dependent vasodilation.[54] Other clinical studies have explored higher doses, typically between 3 and 6 g per day.[13]
• Dyslipidemia: The evidence regarding taurine's effect on blood lipid profiles is inconsistent. Some clinical trials have reported beneficial effects, showing that taurine supplementation can lead to reductions in total cholesterol and triglyceride levels.[12] However, a 2025 meta-analysis focusing on overweight and obese individuals found that while taurine improved markers of glycemic control, it did not have a significant effect on total cholesterol or triglycerides.[55] Another meta-analysis also reported no significant effect on these parameters.[56] This discrepancy suggests that the lipid-lowering effects of taurine may be context-dependent, potentially varying with the patient population and baseline metabolic status.

5.3. Investigated Metabolic and Endocrine Applications

• Diabetes Mellitus: Taurine has shown considerable promise as an adjunct therapy for both type 1 and type 2 diabetes. Its mechanisms are thought to involve enhancing insulin sensitivity and protecting against the long-term complications of hyperglycemia.[12] A recent randomized clinical trial in 120 patients with type 2 diabetes found that supplementation with 3 g of taurine per day (1 g three times daily) for eight weeks significantly reduced fasting insulin levels and improved insulin resistance (as measured by HOMA-IR).[57] The same study also demonstrated significant reductions in markers of inflammation (hs-CRP, TNF-α) and endothelial dysfunction, suggesting a protective effect against diabetes-related vascular complications.[57]
• Obesity: The efficacy of taurine as a weight-loss agent is currently debated. While some studies and preclinical data suggest it could aid in weight reduction by modulating lipid metabolism and energy expenditure, the clinical evidence is conflicting.[33] A meta-analysis found no significant effect of taurine on Body Mass Index (BMI) in obese populations.[56] In contrast, a more recent meta-analysis from 2025 reported that taurine supplementation was effective in reducing body weight and BMI in overweight adults, but not in those classified as obese.[55] This suggests a potential differential effect based on the degree of adiposity. A clinical trial (NCT04279600) is currently underway to further investigate the effects of 3 g of taurine per day combined with exercise on energy metabolism and body composition in obese women.[58]

5.4. Investigated Neurological and CNS Applications

• Neuroprotection: Preclinical models have provided strong evidence for taurine's neuroprotective capabilities. It has been shown to protect neurons from toxicity induced by amyloid-β peptides and glutamate receptor agonists, suggesting a potential therapeutic role in conditions like Alzheimer's disease and ischemic stroke.[19]
• Epilepsy: Given its role as a GABAergic and glycinergic agonist, taurine has inherent anticonvulsant properties. Animal studies and preliminary human trials have suggested it may be beneficial in some forms of epilepsy.[1] However, the effects in human clinical studies have been inconsistent, and it is not currently recommended as a standard treatment.[34]
• Cognitive Function: Despite its widespread inclusion in "energy drinks" marketed for mental performance, a systematic review and meta-analysis published in 2025, which included seven randomized controlled trials, concluded that there is insufficient evidence to support the efficacy of taurine supplementation for enhancing cognitive function in either healthy or cognitively impaired individuals.[59] A small subgroup analysis did suggest a potential benefit in improving Mini-Mental State Examination (MMSE) scores when used in combination with other therapeutic drugs, but this finding requires further investigation.[59]

5.5. Other Investigated Applications

• Hepatitis: Taurine may have hepatoprotective effects. Clinical studies have suggested that supplementation can improve liver function markers (e.g., ALT, AST) in patients with both acute and chronic hepatitis.[11] Dosages used in these studies have been relatively high, such as 4 g three times daily for acute hepatitis and 2 g three times daily for chronic hepatitis.[50]
• Athletic Performance: Taurine is a common ingredient in sports supplements, purported to enhance performance. A review of 19 studies identified several potential benefits, including increased oxygen uptake, prolonged time to fatigue, and reduced exercise-induced muscle damage.[12] The suggested effective dose is 1–3 grams taken 1–3 hours prior to exercise.[12] However, the review also noted that the observed effects are often small and inconsistent across studies, indicating that more research is needed to confirm these benefits.[12]
• Periodontitis: The anti-inflammatory properties of taurine have led to its investigation in oral health. At least one completed clinical trial (NCT04772508) has explored the topical application of taurine with an amnion membrane to reduce levels of the pro-inflammatory cytokine TNF-α in the gingival crevicular fluid of patients with periodontitis.[61]

5.6. The Taurine and Aging Controversy

The role of taurine in the aging process has recently become a subject of significant scientific debate, sparked by two high-profile, yet conflicting, studies.

• The Pro-Longevity Hypothesis: A highly influential study published in Science in 2023 proposed that taurine deficiency is a driver of aging. The researchers presented cross-sectional data showing that circulating taurine concentrations decline dramatically with age in mice, monkeys, and humans, with levels in 60-year-old humans being only about one-third of those in 5-year-olds.[62] Crucially, they demonstrated that supplementing middle-aged mice with taurine extended their median lifespan by 10–12% and improved numerous markers of healthspan, including increased bone mass, enhanced muscle endurance, reduced insulin resistance, and a more youthful immune profile. At the cellular level, taurine supplementation was found to decrease the number of senescent "zombie cells".[62]
• The Counter-Evidence: In 2025, a subsequent study, also published in Science by a team of NIH researchers, directly challenged this hypothesis.[64] Using a longitudinal study design—tracking the same individuals over time—across multiple cohorts of humans, monkeys, and mice, they found that circulating taurine levels did not decline with age. Instead, they either increased or remained stable.[64] They also noted that the variation in taurine levels between individuals was far greater than any changes observed with age. Based on these findings, they concluded that taurine is unlikely to be a reliable biomarker of aging and that a simple deficiency model is not supported by longitudinal data.[65]
• Synthesis and Analysis: This scientific discrepancy highlights the complexity of aging research and the importance of study design. The conflict between the cross-sectional data (comparing different individuals at one time point) and the longitudinal data (tracking the same individuals over time) is at the heart of the debate. It is possible that the initial findings were influenced by cohort effects or other confounding variables. However, even if a decline in taurine is not a universal driver of aging, this does not negate the potential for taurine to act as a pharmacological agent to promote healthspan. The robust benefits seen in the mouse supplementation study—such as improved mitochondrial function and reduced inflammation—could still be relevant for mitigating age-related decline, functioning as a "geroprotector" rather than simply reversing a deficiency. The observed increase in taurine levels after exercise also suggests its role may be more dynamic, perhaps as part of an adaptive stress response, rather than a static biomarker.[63] Further research, including ongoing human clinical trials, is needed to resolve this controversy and determine if the pharmacological benefits of taurine can be harnessed to improve human health in old age.[64]

Indication	Dosage & Duration	Patient Population	Key Outcomes	Source(s)
Congestive Heart Failure	2-6 g/day for 4-8 weeks	NYHA Class II-IV patients	Improved left ventricular function, exercise capacity, and symptoms.	50
Prehypertension	1.6 g/day for 12 weeks	120 prehypertensive adults	Significant reduction in systolic (↓7.2 mmHg) and diastolic (↓4.7 mmHg) blood pressure.	42
Type 2 Diabetes	3 g/day (1g TID) for 8 weeks	120 T2DM patients	Significant reduction in fasting insulin, HOMA-IR, inflammation (hs-CRP, TNF), and endothelial dysfunction markers.	57
Chronic Hepatitis	6 g/day (2g TID) for 3 months	Patients with chronic hepatitis	Significant improvement in liver function markers (ALT, AST).	13
Athletic Performance	1-3 g, 1-3 hours pre-workout	Athletes / Active individuals	Small and inconsistent improvements in oxygen uptake and time to fatigue; potential reduction in muscle damage.	12
Obesity / Overweight	1.5-3 g/day for 8+ weeks	Overweight and obese adults	Conflicting results; one meta-analysis showed weight/BMI reduction in overweight but not obese individuals.	55

VI. Safety, Tolerability, and Risk Management

Taurine is widely regarded as having a high safety profile, particularly when consumed at levels found in the diet and through moderate supplementation. However, a comprehensive risk assessment requires consideration of its adverse effect profile, specific contraindications and precautions, emerging toxicological data, and potential for drug-drug interactions.

6.1. General Safety and Tolerability

• Observed Safe Level: Extensive human data supports the safety of taurine supplementation. An observed safe upper level (OSL) has been established at 3 grams per day for long-term use.[50] This level is associated with a high degree of confidence that no adverse effects will occur.[67] The European Food Safety Authority (EFSA) has suggested that daily intakes up to 6 grams are safe.[12] Clinical trials have utilized doses as high as 10 g/day for up to six months without reporting significant adverse events, though data on the safety of such high doses over longer periods is limited.[50]
• Adverse Effects Profile: When taken as a standalone supplement within recommended doses, taurine is exceptionally well-tolerated. No adverse events have been reported in numerous clinical studies.[13] When side effects do occur, they are typically mild, transient, and gastrointestinal in nature, such as nausea, stomach pain, or diarrhea. Headache and dizziness have also been reported, though less commonly.[68]
• Confounding Factors (Energy Drinks): It is critically important to differentiate the safety profile of pure taurine from that of taurine-containing energy drinks. Numerous reports of adverse cardiovascular events (e.g., tachycardia, palpitations, hypertension), as well as neurological symptoms (e.g., anxiety, insomnia, jitteriness), have been associated with the consumption of these beverages.[56] However, these effects are overwhelmingly attributed to the high concentrations of other ingredients, primarily caffeine and sugar, and their synergistic effects, rather than to taurine itself.[56] Some research even suggests that taurine may have a protective effect, potentially mitigating some of the adverse cardiovascular consequences of high caffeine intake.[72]

6.2. Contraindications and Precautions

• Hypersensitivity: The only established contraindication for taurine is a known hypersensitivity to the substance.[50]
• Special Populations:
• Pregnancy and Lactation: Taurine is a natural and vital component of breast milk and is essential for normal fetal and neonatal development. However, there is insufficient data on the safety of high-dose supplementation during pregnancy and lactation. Therefore, it is recommended that individuals in these groups limit their intake to amounts typically found in food.[13]
• Children: Taurine is commonly consumed in food and is considered possibly safe when used as a medicine in children for up to 12 weeks.[11] However, there is a general caution against the long-term use of high doses of single amino acids in children due to the theoretical risk of creating a negative nitrogen balance and potentially affecting growth.[30]
• Renal Impairment: Individuals with pre-existing kidney disease should use taurine with caution. As the kidneys are responsible for regulating taurine levels and excreting any excess, high-dose supplementation could place an additional burden on compromised renal function.[30]
• Hypotension: Due to its demonstrated blood pressure-lowering effects, taurine should be used cautiously by individuals who already have low blood pressure, as it may exacerbate this condition.[56]
• Allergies: A specific precaution exists for individuals with known allergies to sulfites or sulfonamides. Due to its sulfur-containing structure, it is recommended that these individuals avoid taurine doses above 200 mg to prevent the possibility of allergic reactions, which can range from mild symptoms to severe anaphylaxis.[56]

6.3. Emerging Toxicological Concerns

• Leukemia: While generally considered safe, a recent preclinical study published in Nature has introduced a significant toxicological consideration. The research demonstrated that myeloid leukemia cells are unable to synthesize their own taurine and are dependent on its uptake from the bone marrow microenvironment via the SLC6A6 transporter.[15] This imported taurine was shown to fuel cancer cell proliferation by promoting glycolysis. Blocking the SLC6A6 transporter inhibited the growth of leukemia in both mouse models and human cell samples.[15] These findings suggest that high-dose taurine supplementation could potentially promote the growth of existing myeloid cancers and therefore warrants caution in this specific patient population until further research is conducted.[15]

6.4. Drug-Drug Interactions

Taurine has the potential to interact with several classes of medications through both pharmacodynamic and pharmacokinetic mechanisms.

• Pharmacodynamic Interactions:
• Antihypertensive Drugs: Taurine can have an additive effect with medications that lower blood pressure. Co-administration could lead to hypotension. Patients taking antihypertensive drugs should monitor their blood pressure closely if they begin taurine supplementation.[11]
• CNS Depressants: As an agonist at GABA and glycine receptors, taurine may theoretically potentiate the sedative effects of other CNS depressants, including benzodiazepines, barbiturates, and alcohol.[39]
• Antiplatelet and Anticoagulant Agents: Taurine has been observed to decrease platelet aggregation, which could potentially increase the risk of bleeding when combined with antiplatelet drugs (e.g., aspirin) or anticoagulants.[50]
• Pharmacokinetic Interactions:
• Lithium: Taurine may possess diuretic properties, which could decrease the renal clearance of lithium. This could lead to an accumulation of lithium in the body, increasing the risk of toxicity. Patients on lithium therapy should be closely monitored, and a dose adjustment of lithium may be necessary if taurine is co-administered.[11]
• CYP450 System: Taurine has been identified as an inhibitor of the cytochrome P450 2E1 (CYP2E1) isoenzyme.[13] This could potentially alter the metabolism and affect the plasma concentrations of any co-administered drugs that are substrates of CYP2E1.[13]
• Chemotherapy Agents: A number of minor interactions have been reported where various chemotherapeutic agents (e.g., fluorouracil, docetaxel, paclitaxel, gemcitabine) may decrease circulating taurine levels, though the clinical significance of this is not well established.[50]

Interacting Drug/Class	Mechanism	Potential Outcome	Clinical Recommendation
Antihypertensives	Additive Pharmacodynamic (Hypotension)	Excessive reduction in blood pressure (hypotension).	Monitor blood pressure closely. Use with caution.
Lithium	Reduced Renal Clearance (Diuretic Effect)	Increased lithium levels and risk of toxicity.	Monitor serum lithium levels. Lithium dose reduction may be required.
CNS Depressants (e.g., Benzodiazepines)	Additive Pharmacodynamic (Sedation)	Enhanced sedation and CNS depression.	Use with caution, especially when operating machinery.
CYP2E1 Substrates	Pharmacokinetic (Enzyme Inhibition)	Altered metabolism and plasma levels of the substrate drug.	Review co-medications for potential CYP2E1 substrates.
Antiplatelet/Anticoagulant Drugs	Additive Pharmacodynamic (Anti-aggregation)	Increased risk of bleeding.	Use with caution and monitor for signs of bleeding.

VII. Regulatory Status and Formulations

The regulatory classification of taurine is notably complex and varies significantly across different jurisdictions, reflecting its dual role as an endogenous nutrient and a pharmacologically active agent. Its status can range from a simple food ingredient to a regulated therapeutic good, depending on the country, the product's formulation, and its intended use.

7.1. Global Regulatory Overview

• United States (FDA): In the U.S., taurine holds multiple regulatory statuses. It is listed as "Generally Recognized as Safe" (GRAS) by the Food and Drug Administration (FDA) for specific, limited uses, such as its inclusion as an ingredient in enhanced water beverages at a concentration of 45 parts per million (under GRAS Notice No. 586).[16] It is also approved as a food additive for use as a nutritional supplement in chicken feed.[79] However, when sold as a dietary supplement for human consumption, it does not undergo the rigorous pre-market safety and efficacy review required for pharmaceutical drugs.[79] The FDA has explicitly stated that it has not conducted a formal safety assessment of taurine in the context of its widespread use in energy drinks, and it has cautioned manufacturers about making unsubstantiated health claims.[80]
• European Union (EMA/EFSA): The European Food Safety Authority (EFSA), the EU's risk assessment body, has evaluated taurine multiple times. EFSA concluded in 2009, and reaffirmed in 2015, that exposure to taurine at the levels currently used in energy drinks does not pose a safety concern.[82] Taurine is also authorized as a "nutritional additive" in animal feed for specific species, including cats, dogs, and carnivorous fish, with legally defined maximum content levels to ensure efficacy and safety.[83] EFSA has also reviewed various health claims related to taurine but has generally found insufficient scientific evidence to substantiate claims regarding immune function, cognitive function, or muscle function in the general population.[84]
• Australia (TGA/FSANZ): In Australia, the regulation of taurine is split between two bodies. Food Standards Australia New Zealand (FSANZ) regulates its use in food products. Under the Food Standards Code, taurine is permitted as an additive in "Formulated Caffeinated Beverages" (i.e., energy drinks) up to a maximum level of 2000 mg per one-day quantity of the product.[17] Separately, the Therapeutic Goods Administration (TGA) regulates products that are presented as medicines. A recent regulatory shift has had a significant impact on sports supplements. As of November 30, 2023, any product that is in a dosage form like a tablet, capsule, or pill and makes therapeutic claims related to sports performance (e.g., muscle gain, increased stamina, workout recovery) is now classified as a therapeutic good and must be listed on the Australian Register of Therapeutic Goods (ARTG).[85] Consequently, several taurine supplement products are now officially listed on the ARTG as therapeutic goods.[87]

7.2. Available Formulations and Administration

Taurine is available in a variety of formulations, catering to its diverse applications from dietary supplementation to critical care nutrition.

• Oral Formulations: This is the most common route for supplementation.
• Powder: Pure, unadulterated taurine powder is widely marketed, offering consumers flexibility in dosing. It is typically dissolved in water or other beverages.[89]
• Capsules and Tablets: For convenience, taurine is frequently sold in pre-measured capsules or tablets. Common strengths include 500 mg and 1000 mg.[91]
• Parenteral Formulations: These are used exclusively in clinical and hospital settings for nutritional support when oral or enteral routes are not feasible.
• Intravenous (IV) / Intramuscular (IM) Injection: Compounded formulations of taurine are available, for example as a 50 mg/mL solution, for direct IV or IM administration.[77]
• Total Parenteral Nutrition (TPN): Taurine is a standard ingredient in many commercially available crystalline amino acid solutions used to compound TPN bags. The concentration varies by product, with examples including 0.5 g/1000 mL, 1 g/1000 mL, and 2 g/1000 mL.[8]
• Functional Foods and Beverages:
• Energy Drinks: Taurine is a hallmark ingredient in most energy drinks, typically added at concentrations of 750–1000 mg per 8-ounce (237 mL) serving.[12] The taurine used is synthetic and not derived from animal sources.[71]
• Infant Formula: To mimic the composition of human breast milk, which is naturally rich in taurine, it is added to most cow's milk-based infant formulas.[13]
• Animal Feed: Taurine is a required additive in commercial cat food, as cats have a limited ability to synthesize it and will develop severe health problems, including cardiomyopathy and retinal degeneration, if their diet is deficient.[20]

7.3. Commercial Products and Brand Names

Taurine is marketed globally under numerous brand names, both as a single-ingredient supplement and as a component of multi-ingredient formulations. The following is a representative, non-exhaustive list.

• United States: A wide variety of brands offer taurine supplements, including NOW Foods, Life Extension, BulkSupplements, GNC, Nutricost, Swanson, Solgar, and Nature's Truth.[90] In the pharmaceutical space, it is a component of parenteral nutrition products such as Aminosyn-PF, Premasol, Primene, and Trophamine.[8]
• Australia: Commercially available brands for dietary supplements include Healthwise, Myprotein, and Bulk Nutrients.[89] It is also available in veterinary formulations, such as from Greenpet.[96]
• Europe: The European market features a broad range of brands, including ZeinPharma, Jarrow Formulas, Life Extension, NOW Foods, Swanson, Scitec Nutrition, Nutrend, and BioTech USA.[97]

VIII. Conclusion and Future Directions

8.1. Synthesis of Current Knowledge

This comprehensive analysis confirms that taurine is a molecule of fundamental and multifaceted biological importance. It is not merely a simple amino acid but a dynamic regulator of cellular and systemic physiology. Its unique chemical structure as an amino sulfonic acid underpins its diverse roles, from maintaining cellular volume as an osmolyte and facilitating lipid digestion via bile salt conjugation, to modulating cardiovascular function and protecting tissues from oxidative and inflammatory stress.[4] Its status as a conditionally essential nutrient is well-established, highlighting its critical importance during early life and in certain disease states where endogenous synthesis is insufficient.[4] The pharmacological profile of taurine is complex, involving interactions with key neurotransmitter systems, potentiation of mitochondrial function, and regulation of calcium signaling. This profile, combined with a strong record of safety at therapeutic doses, makes taurine a compelling molecule in both nutritional science and pharmacology.[19] While its use in pediatric parenteral nutrition is standard practice and its efficacy in congestive heart failure is recognized with regulatory approval in Japan, its broader therapeutic potential remains an area of active and promising investigation.

8.2. Gaps in Knowledge and Future Research Directions

Despite the extensive body of research on taurine, significant gaps in knowledge remain, and several key areas warrant focused investigation to translate its potential into clinical practice. The trajectory of taurine research is clearly evolving from a primary focus on its role in preventing nutritional deficiency to a more sophisticated exploration of its potential as a pharmacological intervention. The central questions for the future are not about maintaining baseline levels in healthy individuals, but whether supraphysiological doses can be strategically employed as a therapeutic agent to actively modulate disease pathways, even in those without a clear deficiency. This paradigm shift reframes the research agenda, prioritizing rigorous pharmacological studies over simple supplementation trials.

• Large-Scale Clinical Trials: The most pressing need is for large-scale, long-term, multicenter randomized controlled trials (RCTs). While preliminary data for conditions like hypertension, type 2 diabetes, and congestive heart failure (outside of Japan) are encouraging, they are often based on smaller studies with limited duration.[18] Future trials must be adequately powered to definitively establish efficacy, determine optimal dosing regimens, and assess long-term safety. Head-to-head trials comparing taurine to standard-of-care medications would be particularly valuable in defining its place in therapy.[12]
• Clarifying the Role in Aging: The recent controversy surrounding taurine's relationship with aging highlights a critical area for further research. The conflicting findings from major cross-sectional and longitudinal studies need to be reconciled.[62] Future research should move beyond simply measuring circulating levels and instead investigate tissue-specific concentrations, the activity of the TauT transporter, and the impact of taurine supplementation on validated biomarkers of biological aging in humans. An ongoing clinical trial is already beginning to address this, but more work is needed to determine if taurine can act as a geroprotective agent to enhance healthspan, regardless of whether its decline is a universal driver of aging.[64]
• Neurological and Cognitive Applications: The potential of taurine in neurodegenerative diseases such as Alzheimer's and Parkinson's disease is compelling but remains largely confined to preclinical evidence.[10] Rigorous, well-designed clinical trials are essential to determine if the neuroprotective effects observed in animal models can be translated into meaningful clinical benefits for patients.
• Context-Dependent Safety and Toxicology: The preclinical findings linking taurine uptake to the proliferation of leukemia cells underscore the need to move beyond a simplistic, "one-size-fits-all" view of its safety.[15] Future toxicological studies should investigate the effects of high-dose taurine supplementation in various pathological contexts, particularly across different cancer types and in patients with specific genetic predispositions. This will be crucial for developing nuanced safety guidelines and identifying populations for whom supplementation may be contraindicated.
• Novel Therapeutic Avenues (Long COVID-19): The initiation of a major clinical trial in Canada to evaluate taurine as a treatment for long COVID-19 represents an exciting and novel research direction.[101] Given the overlapping symptoms of long COVID-19 (e.g., fatigue, cognitive dysfunction, exercise intolerance) with conditions where taurine has shown potential benefit, this is a logical and promising area of investigation. The results of this trial could open up a completely new therapeutic application for taurine in post-viral syndromes.

Works cited

1. Showing metabocard for Taurine (HMDB0000251) - Human Metabolome Database, accessed September 25, 2025, https://www.hmdb.ca/metabolites/HMDB00251
2. en.wikipedia.org, accessed September 25, 2025, [https://en.wikipedia.org/wiki/Taurine#:~:text=Taurine%20(%2F%CB%88t%C9%94%CB%90r,in%20mammalian%20tissues%20and%20organs.](https://www.google.com/url?q=https://en.wikipedia.org/wiki/Taurine%23:~:text%3DTaurine%2520(%252F%25CB%2588t%25C9%2594%25CB%2590r,in%2520mammalian%2520tissues%2520and%2520organs.&sa=D&source=editors&ust=1758785919241436&usg=AOvVaw2Qs-6cH28pflhlXR1jv69J)
3. Taurine | C2H7NO3S | CID 1123 - PubChem, accessed September 25, 2025, https://pubchem.ncbi.nlm.nih.gov/compound/Taurine
4. Review: Taurine: A “very essential” amino acid - PMC - PubMed Central, accessed September 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3501277/
5. Taurine: A conditionally essential amino acid in humans? An overview in health and disease, accessed September 25, 2025, https://www.researchgate.net/publication/10961858_Taurine_A_conditionally_essential_amino_acid_in_humans_An_overview_in_health_and_disease
6. CAS 107-35-7 Taurine - Alfa Chemistry, accessed September 25, 2025, https://www.alfa-chemistry.com/product/taurine-cas-107-35-7-499322.html
7. Review: taurine: a "very essential" amino acid - PubMed, accessed September 25, 2025, https://pubmed.ncbi.nlm.nih.gov/23170060/
8. Taurine: Uses, Interactions, Mechanism of Action | DrugBank Online, accessed September 25, 2025, https://go.drugbank.com/drugs/DB01956
9. Effects and Mechanisms of Taurine as a Therapeutic Agent - PubMed, accessed September 25, 2025, https://pubmed.ncbi.nlm.nih.gov/29631391/
10. Functional Role of Taurine in Aging and Cardiovascular Health: An Updated Overview, accessed September 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10574552/
11. TAURINE: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews, accessed September 25, 2025, https://www.webmd.com/vitamins/ai/ingredientmono-1024/taurine
12. What Is Taurine? Benefits, Side Effects, and More - Healthline, accessed September 25, 2025, https://www.healthline.com/nutrition/what-is-taurine
13. Taurine Uses, Benefits & Dosage - Drugs.com, accessed September 25, 2025, https://www.drugs.com/npp/taurine.html
14. Drug Interaction Report: taurine, valsartan - Drugs.com, accessed September 25, 2025, https://www.drugs.com/interactions-check.php?drug_list=4071-0,2288-0&professional=1
15. A Downside of Taurine: It Drives Leukemia Growth - University of Rochester Medical Center, accessed September 25, 2025, https://www.urmc.rochester.edu/news/story/a-downside-of-taurine-it-drives-leukemia-growth
16. GRAS Notices - cfsanappsexternal.fda.gov, accessed September 25, 2025, https://www.hfpappexternal.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=586&sort=GRN_No&order=ASC&startrow=1&type=basic&search=22
17. APPLICATION 394 FORMULATED CAFFEINATED BEVERAGES (formerly Energy Drinks) - Food Standards Australia New Zealand, accessed September 25, 2025, https://www.foodstandards.gov.au/sites/default/files/food-standards-code/applications/Documents/A394Explan.pdf
18. Taurine: A Comprehensive Review of Its Origin, Pharmacological Properties, Potential Health Benefits, Therapeutic Applications, and Safety Profile - SciOpen, accessed September 25, 2025, https://www.sciopen.com/article/10.26599/FSHW.2024.9250433
19. Effects and Mechanisms of Taurine as a Therapeutic Agent - PMC - PubMed Central, accessed September 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5933890/
20. Taurine - Wikipedia, accessed September 25, 2025, https://en.wikipedia.org/wiki/Taurine
21. Taurine - the NIST WebBook - National Institute of Standards and Technology, accessed September 25, 2025, https://webbook.nist.gov/cgi/cbook.cgi?ID=107-35-7
22. Taurine (β-Aminoethylsulfonic Acid, NSC 32428, CAS Number: 107-35-7), accessed September 25, 2025, https://www.caymanchem.com/product/27031/taurine
23. 2-Aminoethanesulfonic Acid 107-35-7 - TCI Chemicals, accessed September 25, 2025, https://www.tcichemicals.com/MX/en/p/A0295
24. L-TAURINE | CAMEO Chemicals | NOAA, accessed September 25, 2025, https://cameochemicals.noaa.gov/chemical/21060
25. Taurine | CAS 107-35-7 - Order from AdipoGen, accessed September 25, 2025, https://adipogen.com/cdx-t0187-taurine.html
26. Physiological role of taurine – from organism to organelle - Miloa Academy, accessed September 25, 2025, https://academy.miloa.eu/wp-content/uploads/2020/06/Lambert-et-al.-physiological-role-of-taurine...-2015.pdf
27. Taurine Nutrition - Cambridge University Press, accessed September 25, 2025, https://www.cambridge.org/core/services/aop-cambridge-core/content/view/76CD47EE5D46E1DA968CC6707F68C3C5/S0954422488000101a.pdf/taurine-nutrition.pdf
28. Taurine: Synthesis, Dietary Sources, Homeostasis, and Cellular Compartmentalization, accessed September 25, 2025, https://benthamscience.com/public/chapter/18972
29. [Taurine and its potential therapeutic application] - PubMed, accessed September 25, 2025, https://pubmed.ncbi.nlm.nih.gov/18305447/
30. Taurine - Content - Health Encyclopedia - University of Rochester Medical Center, accessed September 25, 2025, https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=19&contentid=Taurine
31. 7 Foods High in Taurine, and Why to Add Them to Your Diet - GoodRx, accessed September 25, 2025, https://www.goodrx.com/well-being/diet-nutrition/foods-high-in-taurine
32. Top Foods High in Taurine - WebMD, accessed September 25, 2025, https://www.webmd.com/diet/foods-high-in-taurine
33. Taurine: Sources, Uses, and More - WebMD, accessed September 25, 2025, https://www.webmd.com/vitamins-and-supplements/what-is-taurine
34. What is taurine? Benefits and side effects - Medical News Today, accessed September 25, 2025, https://www.medicalnewstoday.com/articles/326476
35. Taurine and cardiac disease: state of the art and perspectives, accessed September 25, 2025, https://cdnsciencepub.com/doi/10.1139/cjpp-2019-0313
36. Functional Role of Taurine in Aging and Cardiovascular Health: An Updated Overview, accessed September 25, 2025, https://www.mdpi.com/2072-6643/15/19/4236
37. Taurine Physiological Functions - News-Medical.net, accessed September 25, 2025, https://www.news-medical.net/health/Taurine-Physiological-Functions.aspx
38. Pharmacology of taurine - PubMed, accessed September 25, 2025, https://pubmed.ncbi.nlm.nih.gov/18605222/
39. Showing BioInteractions for Taurine (DB01956) | DrugBank Online, accessed September 25, 2025, https://go.drugbank.com/drugs/DB01956/biointeractions
40. Effects and Mechanisms of Taurine as a Therapeutic Agent - Semantic Scholar, accessed September 25, 2025, https://www.semanticscholar.org/paper/Effects-and-Mechanisms-of-Taurine-as-a-Therapeutic-Schaffer-Kim/fdaf249c5df55866a6caeaf1af23128982b862cf
41. Mechanisms Underlying Development of Taurine-Deficient Cardiomyopathy - MDPI, accessed September 25, 2025, https://www.mdpi.com/2673-3846/1/2/10
42. Taurine in Congestive Heart Failure - ClinMed International Library, accessed September 25, 2025, https://clinmedjournals.org/articles/ijcc/international-journal-of-clinical-cardiology-ijcc-8-246.pdf
43. Interaction between the actions of taurine and angiotensin II - PubMed, accessed September 25, 2025, https://pubmed.ncbi.nlm.nih.gov/10949914/
44. Chemical structure of taurine showing its two functional groups, the... - ResearchGate, accessed September 25, 2025, https://www.researchgate.net/figure/Chemical-structure-of-taurine-showing-its-two-functional-groups-the-amino-group-and-the_fig4_345320125
45. Pharmacokinetics of Oral Taurine in Healthy Volunteers - PMC, accessed September 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3275936/
46. Nutritional requirement for taurine in patients receiving long-term parenteral nutrition - PubMed, accessed September 25, 2025, https://pubmed.ncbi.nlm.nih.gov/3917547/
47. [Taurine requirement of premature infants in parenteral nutrition] - PubMed, accessed September 25, 2025, https://pubmed.ncbi.nlm.nih.gov/1501617/
48. Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot study | British Journal of Nutrition - Cambridge University Press, accessed September 25, 2025, https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/taurine-status-and-response-to-intravenous-taurine-supplementation-in-adults-with-shortbowel-syndrome-undergoing-longterm-parenteral-nutrition-a-pilot-study/32135D70157A24A19288E6F9CEF59C16
49. Taurine Nutrition in Patients Undergoing Tpn - Joel Kopple - Grantome, accessed September 25, 2025, https://grantome.com/grant/NIH/R01-DK033112-04
50. Indication-specific dosing for mega taurine (taurine), frequency ..., accessed September 25, 2025, https://reference.medscape.com/drug/mega-taurine-taurine-344595
51. The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease - PMC - PubMed Central, accessed September 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7551180/
52. The potential health benefits of taurine in cardiovascular disease - PMC - PubMed Central, accessed September 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC2586397/
53. Insights into the cardiovascular benefits of taurine: a systematic review and meta-analysis, accessed September 25, 2025, https://pubmed.ncbi.nlm.nih.gov/39148075/
54. Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension | Hypertension - AHA Journals, accessed September 25, 2025, https://www.ahajournals.org/doi/10.1161/hypertensionaha.115.06624
55. Effect of Long-Term Taurine Supplementation on the Lipid and Glycaemic Profile in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis - PMC - PubMed Central, accessed September 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11722866/
56. Taurine benefits, dosage, and side effects - Examine.com, accessed September 25, 2025, https://examine.com/supplements/taurine/
57. Protective and therapeutic effectiveness of taurine supplementation plus low calorie diet on metabolic parameters and endothelial markers in patients with diabetes mellitus: a randomized, clinical trial - PMC, accessed September 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9308194/
58. Study Details | NCT04279600 | Taurine Supplementation and Training Effects on Energy Metabolism, Inflammation and Oxidative Stress in Obese Women | ClinicalTrials.gov, accessed September 25, 2025, https://clinicaltrials.gov/study/NCT04279600
59. Effects of taurine supplementation on cognitive function: a systematic review and meta-analysis of randomised controlled trials | Request PDF - ResearchGate, accessed September 25, 2025, https://www.researchgate.net/publication/391446290_Effects_of_taurine_supplementation_on_cognitive_function_a_systematic_review_and_meta-analysis_of_randomised_controlled_trials
60. Dietary amino acid taurine ameliorates liver injury in chronic hepatitis patients - PubMed, accessed September 25, 2025, https://pubmed.ncbi.nlm.nih.gov/17690950/
61. Taurine Completed Phase Trials for Periodontitis Treatment | DrugBank Online, accessed September 25, 2025, https://go.drugbank.com/drugs/DB01956/clinical_trials?conditions=DBCOND0010286&phase=&purpose=treatment&status=completed
62. Taurine May Be a Key to Longer and Healthier Life | ColumbiaDoctors, accessed September 25, 2025, https://www.columbiadoctors.org/news/taurine-may-be-key-longer-and-healthier-life
63. A molecule already produced in our bodies, taurine, may be the key to a longer and healthier life, accessed September 25, 2025, https://www.onjcri.org.au/news/molecule-produced-in-bodies-taurine-may-be-key-to-longer-and-healthier-life/
64. New study raises big questions about taurine as anti-aging supplement | Live Science, accessed September 25, 2025, https://www.livescience.com/health/ageing/taurine-is-not-a-reliable-biomarker-of-anything-yet-study-challenges-hype-over-anti-aging-supplement
65. NIH researchers conclude that taurine is unlikely to be a good aging biomarker - EurekAlert!, accessed September 25, 2025, https://www.eurekalert.org/news-releases/1085832
66. NIH researchers conclude that taurine is unlikely to be a good aging biomarker, accessed September 25, 2025, https://www.nih.gov/news-events/news-releases/nih-researchers-conclude-taurine-unlikely-be-good-aging-biomarker
67. Taurine Toxicity - News-Medical.net, accessed September 25, 2025, https://www.news-medical.net/health/Taurine-Toxicity.aspx
68. Taurine Benefits and Side Effects - Cleveland Clinic Health Essentials, accessed September 25, 2025, https://health.clevelandclinic.org/taurine
69. Taurine : Indications, Uses, Dosage, Drugs Interactions, Side effects - Medical Dialogues, accessed September 25, 2025, https://medicaldialogues.in/generics/taurine-2725822
70. Caffeine and Taurine from Energy Drinks—A Review - MDPI, accessed September 25, 2025, https://www.mdpi.com/2079-9284/11/1/12
71. Taurine in Energy Drinks: Benefits, Side Effects & Safety - G FUEL, accessed September 25, 2025, https://gfuel.com/blogs/news/taurine-in-energy-drinks
72. Taurine: Benefits and risks - Medical News Today, accessed September 25, 2025, https://www.medicalnewstoday.com/articles/326714
73. Taurine: Heart Disease Uses, Warnings, Side Effects, Dosage - MedicineNet, accessed September 25, 2025, https://www.medicinenet.com/taurine/article.htm
74. What are the side effects of Taurine? - Patsnap Synapse, accessed September 25, 2025, https://synapse.patsnap.com/article/what-are-the-side-effects-of-taurine
75. What You Don't Know About Taurine, a Common Energy Drink Ingredient, Could Be Putting Your Health at Risk, accessed September 25, 2025, https://jacksonhealth.org/what-you-dont-know-about-taurine-a-common-energy-drink-ingredient-could-be-putting-your-health-at-risk/
76. What is Taurine used for? - Patsnap Synapse, accessed September 25, 2025, https://synapse.patsnap.com/article/what-is-taurine-used-for
77. Taurine Injection, 50mg/mL | Olympia Pharmaceuticals, accessed September 25, 2025, https://www.olympiapharmacy.com/product/l-taurine/
78. Taurine in energy drinks: What is it? - Mayo Clinic, accessed September 25, 2025, https://www.mayoclinic.org/healthy-lifestyle/nutrition-and-healthy-eating/expert-answers/taurine/faq-20058177
79. Taurine - Agricultural Marketing Service, accessed September 25, 2025, https://www.ams.usda.gov/sites/default/files/media/Taurine%20report%202011.pdf
80. Letter - Senator Dick Durbin, accessed September 25, 2025, https://www.durbin.senate.gov/imo/media/doc/09112012FDA.pdf
81. Agency Response Letter GRAS Notice No. GRN 000586 - FDA, accessed September 25, 2025, https://www.fda.gov/food/gras-notice-inventory/agency-response-letter-gras-notice-no-grn-000586
82. Taurine is not a stimulant, but it plays an important role in several physiological functions. - Energy Drinks Europe, accessed September 25, 2025, https://www.energydrinkseurope.org/2020/01/03/taurine-is-not-a-stimulant-but-it-plays-an-important-role-in-several-physiological-functions/
83. COMMISSION IMPLEMENTING REGULATION (EU) 2015/ 722 - of 5 May 2015 - concerning the authorisation of taurine as, accessed September 25, 2025, https://www.legislation.gov.uk/eur/2015/722/pdfs/eur_20150722_adopted_en.pdf
84. Taurine related health claims - EFSA - European Union, accessed September 25, 2025, https://www.efsa.europa.eu/en/efsajournal/pub/2035
85. Supplement reforms - is your product now a therapeutic good - Ashurst, accessed September 25, 2025, https://www.ashurst.com/en/insights/supplement-reforms---is-your-product-now-a-therapeutic-good/
86. New TGA Legislation | How it affects you - Myprotein Australia, accessed September 25, 2025, https://au.myprotein.com/blog/nutrition/new-tga-legislation-how-it-affects-you/
87. Taurine 1000 (421370) | Therapeutic Goods Administration (TGA), accessed September 25, 2025, https://www.tga.gov.au/resources/artg/421370
88. Taurine (481728) | Therapeutic Goods Administration (TGA), accessed September 25, 2025, https://www.tga.gov.au/resources/artg/481728
89. Healthwise Taurine Powder 300g - Australian Organic Products, accessed September 25, 2025, https://australianorganicproducts.com.au/products/healthwise-taurine-powder-300g
90. Taurine Powder Supplements: Best Brands & Sizes - Target, accessed September 25, 2025, https://www.target.com/s/taurine+powder
91. Taurine Caps - Amino Acids - Myprotein Australia, accessed September 25, 2025, https://au.myprotein.com/p/sports-nutrition/taurine-caps/12506111/
92. Taurine Tablets - Walmart, accessed September 25, 2025, https://www.walmart.com/c/kp/taurine-tablets
93. Prescribing information available here for the Fresenius Kabi parenteral nutrition macronutrient products, please scroll. SMOFli, accessed September 25, 2025, https://www.fresenius-kabi.com/content/dam/fresenius-kabi/gb/products/product-documents/parenteral-nutrition/smoflipid/Macronutrient%20Prescribing%20Information.pdf.coredownload.inline.pdf
94. Taurine Supplements | GNC, accessed September 25, 2025, https://www.gnc.com/buy/taurine
95. Taurine - Pure Amino Acid with fast delivery under 3kgs - Bulk Nutrients, accessed September 25, 2025, https://www.bulknutrients.com.au/products/taurine
96. Taurine Powder 100% Pure Human Grade - Greenpet, accessed September 25, 2025, https://greenpet.com.au/product/taurine-powder-400g/
97. ZeinPharma Taurine 500 mg, 120 capsules - VitalAbo Online Shop Europe, accessed September 25, 2025, https://www.vitalabo.com/zeinpharma/taurine-500-mg-3
98. Taurine - mass-zone.eu, accessed September 25, 2025, https://mass-zone.eu/en/taurine-c-99_1_10.html
99. www.ebsco.com, accessed September 25, 2025, https://www.ebsco.com/research-starters/health-and-medicine/taurine-therapeutic-supplement#:~:text=There%20is%20strong%20evidence%20that,disease%20have%20not%20been%20determined.
100. Emergence of taurine as a therapeutic agent for neurological disorders - PubMed Central, accessed September 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10479846/
101. U of A clinical trial to test taurine as treatment for long COVID-19 - The Gateway, accessed September 25, 2025, https://thegatewayonline.ca/2024/10/u-of-a-clinical-trial-to-test-taurine-as-treatment-for-long-covid-19/